Memorandum from Frank G.H. Hill,UKHCDO, to Haemophilia Centre Directors, re allocation of phased funds to allow haemophilia patients aged 23 and over to be treated with recombinant products. The memo talks about the funding available from 2003 to 2006 for haemophiliacs from 23 and upwards.